9.17 Delayed Data As of Apr 20 | ![]() Today’s Change | 4.60 Today|||52-Week Range 17.19 | -38.21% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $334.9M |
Savara, Inc. 900 South Capital of Texas Highway Austin Texas 78746 |
Robert Norman Neville | Chairman & Chief Executive Officer |
Taneli Jouhikainen | President & Chief Operating Officer |
David L. Lowrance | Chief Financial Officer |
Cecilia Ganslandt | Vice President-Medical Affairs |
Peter L. Ginsberg | Vice President-Business Development |